How Venture Capital is Investing in Gene Therapy

The video discusses the evolution of personalized medicine over the past decade, highlighting the approval of gene and cell therapies. It explores Relay Therapeutics' integration of technology and biotech, emphasizing the role of machine learning in drug design. The video also addresses the risks in the biotech industry, particularly concerning costs and regulation, and concludes with a look at current innovations and future prospects in biotech, including the potential for increased drug approvals and advancements in precision medicine.

What are the main risks facing the biotech industry today?

How has the entrepreneurial ecosystem in biotech changed in recent years?

What future advancements do you foresee in the field of personalized medicine?